Faisal Khurshid
Stock Analyst at Jefferies
(4.96)
# 103
Out of 5,028 analysts
255
Total ratings
59%
Success rate
68.6%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Reiterated: Buy | n/a | $17.27 | - | 6 | Sep 29, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $230 → $260 | $219.89 | +18.24% | 4 | Sep 8, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $270 | $207.68 | +30.01% | 4 | Sep 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $290 → $330 | $228.03 | +44.72% | 3 | Aug 31, 2026 | |
| IMTX Immatics | Rated: Buy | $18 → $17 | $7.73 | +119.92% | 2 | Aug 25, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $30 → $8 | $3.15 | +153.97% | 2 | Aug 17, 2026 | |
| INSM Insmed | Reiterated: Buy | $160 → $175 | $103.83 | +68.54% | 6 | Aug 6, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $25 | $10.27 | +143.43% | 1 | Jul 31, 2026 | |
| ONC BeOne Medicines AG | Upgraded: Buy | $333 → $380 | $361.65 | +5.07% | 3 | Jul 12, 2026 | |
| ABVX ABIVAX Société Anonyme | Upgraded: Buy | $90 → $158 | $91.73 | +72.24% | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $19.00 | +57.89% | 2 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $8.00 | - | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $76 → $85 | $63.65 | +33.54% | 2 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $37 | $17.83 | +107.52% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $12.92 | +62.54% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $120 | $72.58 | +65.33% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $30.87 | +78.17% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $12.43 | +20.68% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $29.59 | +11.52% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $114.13 | -17.64% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $109.85 | +0.14% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $12.72 | +65.09% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 | $92.45 | +53.60% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $13.78 | -70.97% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $22.88 | -47.55% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $29.51 | +35.55% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.82 | +135.60% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.29 | n/a | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.39 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.93 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.72 | n/a | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.07 | n/a | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $140.63 | n/a | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $92.72 | n/a | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $2 | $6.50 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.21 | n/a | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $3.65 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.04 | n/a | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $69.99 | n/a | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.7611 | n/a | 7 | Nov 9, 2023 |
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.27
Upside: -
Alnylam Pharmaceuticals
Sep 8, 2026
Reiterated: Hold
Price Target: $230 → $260
Current: $219.89
Upside: +18.24%
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: $270
Current: $207.68
Upside: +30.01%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $290 → $330
Current: $228.03
Upside: +44.72%
Immatics
Aug 25, 2026
Rated: Buy
Price Target: $18 → $17
Current: $7.73
Upside: +119.92%
EyePoint
Aug 17, 2026
Reiterated: Buy
Price Target: $30 → $8
Current: $3.15
Upside: +153.97%
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $160 → $175
Current: $103.83
Upside: +68.54%
Monte Rosa Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $25
Current: $10.27
Upside: +143.43%
BeOne Medicines AG
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $361.65
Upside: +5.07%
ABIVAX Société Anonyme
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $91.73
Upside: +72.24%
Jun 30, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $19.00
Upside: +57.89%
Jun 23, 2026
Reiterated: Buy
Price Target: $15 → $8
Current: $8.00
Upside: -
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $63.65
Upside: +33.54%
May 1, 2026
Reiterated: Buy
Price Target: $40 → $37
Current: $17.83
Upside: +107.52%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $12.92
Upside: +62.54%
Mar 25, 2026
Reiterated: Buy
Price Target: $103 → $120
Current: $72.58
Upside: +65.33%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $30.87
Upside: +78.17%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $12.43
Upside: +20.68%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $29.59
Upside: +11.52%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $114.13
Upside: -17.64%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $109.85
Upside: +0.14%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $12.72
Upside: +65.09%
Dec 15, 2025
Reiterated: Buy
Price Target: $142
Current: $92.45
Upside: +53.60%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $13.78
Upside: -70.97%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $22.88
Upside: -47.55%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $29.51
Upside: +35.55%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.82
Upside: +135.60%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.29
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.39
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.93
Upside: n/a
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.72
Upside: n/a
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.07
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $140.63
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $92.72
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $4 → $2
Current: $6.50
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.21
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $3.65
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.04
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $69.99
Upside: n/a
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $0.7611
Upside: n/a